"Queridos amigos y familiares, hoy acudimos a uds....

Brenda esta padeciendo de un Tumor Neurendocrino desde hace dos años y se ha sometido a inumerables tratamientos y estudios oncologicos, sin embargo la enfermedad ha avanzado dejando a Brenda con una calidad de vida significativamente afectada. La ascitis, que es la acumulacion de liquido en el abdomen, le provoca dificultad para respirar y dolor constante que amerita drenar constantemente. Necesitamos de su apoyo para poder acceder a tratamientos mas avanzados y mejorar su calidad de vida, Juntos podremos ayudarla...

El tratamiento incluye inyecciones mensuales de Sandostatin Lar de 30 mg, una cápsula diaria de Lenvatinib y drenaje de ascitis cada 15 a 18 días, sin contar los exámenes adicionales que el médico considere necesarios.

Además, es imprescindible realizar el estudio de perfil de Biomarcadores OncoDeep, que debe hacerse lo más pronto posible en el extranjero, ya que es costoso y no se realiza en el país.

_______________________________________________________

Dear friends and family, today we turn to you...

Brenda has been suffering from a Neuroendocrine Tumor for the past two years and has undergone countless treatments and oncological studies. However, the disease has progressed, leaving Brenda with a significantly affected quality of life. Ascites, which is the accumulation of fluid in the abdomen, causes her difficulty breathing and constant pain that requires frequent drainage. We need your support to access more advanced treatments and improve her quality of life. Together we can help her...

The treatment consists of injections of Sandostatin Lar 30 mg (a total of 2 per month), Lenvatinib (one capsule daily), and drainage of the Ascites every 15 to 18 days. This does not include any tests the doctor may deem necessary and a test, which is costly, called the OncoDeep Biomarker Profile that must be done outside the country.

Attached are one of the initial reports as well as several subsequent ones for you to read and verify the information